These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1386 related articles for article (PubMed ID: 29089348)

  • 1. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
    Dimitrakopoulou VI; Tsilidis KK; Haycock PC; Dimou NL; Al-Dabhani K; Martin RM; Lewis SJ; Gunter MJ; Mondul A; Shui IM; Theodoratou E; Nimptsch K; Lindström S; Albanes D; Kühn T; Key TJ; Travis RC; Vimaleswaran KS; ; ; ; Kraft P; Pierce BL; Schildkraut JM
    BMJ; 2017 Oct; 359():j4761. PubMed ID: 29089348
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study.
    Sun YQ; Brumpton BM; Bonilla C; Lewis SJ; Burgess S; Skorpen F; Chen Y; Nilsen TIL; Romundstad PR; Mai XM
    Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29748306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D and risk of pregnancy related hypertensive disorders: mendelian randomisation study.
    Magnus MC; Miliku K; Bauer A; Engel SM; Felix JF; Jaddoe VWV; Lawlor DA; London SJ; Magnus P; McGinnis R; Nystad W; Page CM; Rivadeneira F; Stene LC; Tapia G; Williams N; Bonilla C; Fraser A
    BMJ; 2018 Jun; 361():k2167. PubMed ID: 29925546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study.
    Jiang X; Dimou NL; Al-Dabhani K; Lewis SJ; Martin RM; Haycock PC; Gunter MJ; Key TJ; Eeles RA; Muir K; Neal D; Giles GG; Giovannucci EL; Stampfer M; Pierce BL; Schildkraut JM; Warren Andersen S; Thompson D; Zheng W; Kraft P; Tsilidis KK;
    Int J Epidemiol; 2019 Oct; 48(5):1416-1424. PubMed ID: 30597039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbrella Review on the Relationship between Vitamin D Levels and Cancer.
    Schömann-Finck M; Reichrath J
    Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Vitamin D Genetic Risk Score and Cancer Risk in a Large Cohort of U.S. Women.
    Chandler PD; Tobias DK; Wang L; Smith-Warner SA; Chasman DI; Rose L; Giovannucci EL; Buring JE; Ridker PM; Cook NR; Manson JE; Sesso HD
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29315215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study.
    Fu Y; Xu F; Jiang L; Miao Z; Liang X; Yang J; Larsson SC; Zheng JS
    BMC Med; 2021 Jul; 19(1):171. PubMed ID: 34325683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.
    Ong JS; Cuellar-Partida G; Lu Y; ; Fasching PA; Hein A; Burghaus S; Beckmann MW; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Vanderstichele A; Anne Doherty J; Anne Rossing M; Chang-Claude J; Eilber U; Rudolph A; Wang-Gohrke S; Goodman MT; Bogdanova N; Dörk T; Dürst M; Hillemanns P; Runnebaum IB; Antonenkova N; Butzow R; Leminen A; Nevanlinna H; Pelttari LM; Edwards RP; Kelley JL; Modugno F; Moysich KB; Ness RB; Cannioto R; Høgdall E; Høgdall CK; Jensen A; Giles GG; Bruinsma F; Kjaer SK; Hildebrandt MA; Liang D; Lu KH; Wu X; Bisogna M; Dao F; Levine DA; Cramer DW; Terry KL; Tworoger SS; Stampfer M; Missmer S; Bjorge L; Salvesen HB; Kopperud RK; Bischof K; Aben KK; Kiemeney LA; Massuger LF; Brooks-Wilson A; Olson SH; McGuire V; Rothstein JH; Sieh W; Whittemore AS; Cook LS; Le ND; Gilks CB; Gronwald J; Jakubowska A; Lubiński J; Kluz T; Song H; Tyrer JP; Wentzensen N; Brinton L; Trabert B; Lissowska J; McLaughlin JR; Narod SA; Phelan C; Anton-Culver H; Ziogas A; Eccles D; Campbell I; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Wu AH; Dansonka-Mieszkowska A; Kupryjanczyk J; Timorek A; Szafron L; Cunningham JM; Fridley BL; Winham SJ; Bandera EV; Poole EM; Morgan TK; Risch HA; Goode EL; Schildkraut JM; Pearce CL; Berchuck A; Pharoah PD; Chenevix-Trench G; Gharahkhani P; Neale RE; Webb PM; MacGregor S
    Int J Epidemiol; 2016 Oct; 45(5):1619-1630. PubMed ID: 27594614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Sample Mendelian Randomization Analysis of Associations Between Periodontal Disease and Risk of Cancer.
    Corlin L; Ruan M; Tsilidis KK; Bouras E; Yu YH; Stolzenberg-Solomon R; Klein AP; Risch HA; Amos CI; Sakoda LC; Vodička P; Rish PK; Beck J; Platz EA; Michaud DS
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34222791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mendelian Randomization Studies Do Not Support a Role for Vitamin D in Coronary Artery Disease.
    Manousaki D; Mokry LE; Ross S; Goltzman D; Richards JB
    Circ Cardiovasc Genet; 2016 Aug; 9(4):349-56. PubMed ID: 27418593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer.
    Gao C; Patel CJ; Michailidou K; Peters U; Gong J; Schildkraut J; Schumacher FR; Zheng W; Boffetta P; Stucker I; Willett W; Gruber S; Easton DF; Hunter DJ; Sellers TA; Haiman C; Henderson BE; Hung RJ; Amos C; Pierce BL; Lindström S; Kraft P;
    Int J Epidemiol; 2016 Jun; 45(3):896-908. PubMed ID: 27427428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrumental variable estimation of the causal effect of plasma 25-hydroxy-vitamin D on colorectal cancer risk: a mendelian randomization analysis.
    Theodoratou E; Palmer T; Zgaga L; Farrington SM; McKeigue P; Din FV; Tenesa A; Davey-Smith G; Dunlop MG; Campbell H
    PLoS One; 2012; 7(6):e37662. PubMed ID: 22701574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a causal relationship between vitamin D and melanoma risk? A Mendelian randomization study.
    Liyanage UE; Law MH; ; Barrett JH; Iles MM; MacGregor S
    Br J Dermatol; 2020 Jan; 182(1):97-103. PubMed ID: 31218665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and overall cancer risk and cancer mortality: a Mendelian randomization study.
    Ong JS; Gharahkhani P; An J; Law MH; Whiteman DC; Neale RE; MacGregor S
    Hum Mol Genet; 2018 Dec; 27(24):4315-4322. PubMed ID: 30508204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher 25-hydroxyvitamin D level is associated with increased risk for Behçet's disease.
    Zhong Z; Su G; Du L; Zhou Q; Li F; Chi W; Liu S; Zhang M; Zuo X; Yang P
    Clin Nutr; 2021 Feb; 40(2):518-524. PubMed ID: 32593521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional Mendelian randomisation analysis of the relationship between circulating vitamin D concentration and colorectal cancer risk.
    He Y; Zhang X; Timofeeva M; Farrington SM; Li X; Xu W; Campbell H; Houlston RS; Tomlinson IP; Theodoratou E; Dunlop MG
    Int J Cancer; 2022 Jan; 150(2):303-307. PubMed ID: 34449871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study.
    Xiao J; Lv J; Wang S; Zhou Y; Chen L; Lu J; Zhang X; Wang X; Gu Y; Lu Q
    BMC Geriatr; 2021 Jun; 21(1):391. PubMed ID: 34187381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study.
    Ye Z; Sharp SJ; Burgess S; Scott RA; Imamura F; ; Langenberg C; Wareham NJ; Forouhi NG
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):35-42. PubMed ID: 25281353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.